inhibitors (Roche, 04693159001; Basle, Switzerland) and phosphorylase inhibitors
(Roche, 04906845001). Protein concentration was determined with a BCA protein
assay kit (Thermo Fisher Scientific, 23227, Massachusetts, USA). Equal amounts
of protein were fractionated on Tris-glycine SDS-polyacrylamide gels and
subjected to electrophoresis and transferred to NC membranes. Membranes were
blocked with TBS containing 5% (w/v) dry milk with 0.1% Tween 20, washed with
TBS containing 0.1% Tween 20 (TBST), and then incubated overnight at
4°C with specific antibodies against TIGAR (1:1,000; Abcam, ab37910;
Cambridge, UK), G6PD (1:1000; CST,#8866; Massachusetts, USA), Ckd5 (1:1000;
Abcam, ab40773), p-ATM (1:1000; Abcam, ab81292), ATM (1:1000; Abcam, ab78),
GAPDH (1:2000; Sigma, SAB1405848) in non-fat milk containing 0.1% NaN3. After
washing in TBST, membranes were incubated with fluorescent secondary antibodies
(1:10,000; Jackon ImmunoResearch, anti-rabbit, 711-035-152, anti-mouse,
715-035-150; West Grove, PA, USA) at room temperature for 1 h.
Immunoreactivity was detected using ODYSSEY INFRARED IMAGER (Li-COR Biosciences,
Nebraska, USA). The signal intensity of primary antibody binding was
quantitatively analyzed with Image J software (W.S. Rasband, Image J, NIH,
Bethesda, MD).